NAPOMENA
Za tačnost unetih podataka o publikacijama, naučnim i umetničkim referencama odgovorni su autori.Nikola Stefanović
Dodatne informacije
-
Lični podaci
- Datum rođenja: 21.01.1984.
- Mesto rođenja: Niš
-
Obrazovanje
- Fakultet: Medicinski fakultet Niš
- Odsek / Grupa / Smer: Farmacija
- Godina diplomiranja: 2009
-
Spisak publikacija
-
Knjige i udžbenici:
Nikola Stefanović, Ivana Damnjanović. Priručnik iz farmakoterapije-pregled odabranih slučajeva iz prakse. Medicinski fakultet Niš, Niš, 2021.
Ivana Nešić, Ivana Damnjanović, Nikola Stefanović. Osnovi savremene farmaceutske prakse. Urednik: Ivana Nešić, Medicinski fakultet Niš, Niš, 2021.
Radmila Veličković-Radovanović, Aleksandra Catić-Đorđević, Ivana Damnjanović, Nikola Stefanović. Priručnik iz farmakokinetike. Urednik: Radmila Veličković-Radovanović, Medicinski fakultet Niš, Niš, 2015.
Radmila Veličković-Radovanović, Aleksandra Catić-Đorđević, Ivana Damnjanović (saradnik), Nikola Stefanović (saradnik). Farmakoepidemiologija. Urednik: Radmila Veličković-Radovanović, Medicinski fakultet Niš, Niš, 2014.
-
Radovi u časopisima sa IMPACT faktorom:
Damnjanović I, Tsyplakova N, Stefanović N, Tošić T, Catić-Đorđević A, Karalis V. Joint use of population pharmacokinetics and machine learning for optimizing antiepileptic treatment in pediatric population. Ther Adv Drug Saf. 2023; 14: 20420986231181337. doi: 10.1177/20420986231181337. (M21)
Jovanović M, Kovačević M, Catić-Đorđević A, Ćulafić M, Stefanović N, Mitić B, et al.. Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria. Braz J Pharm Sci. 2023;59: e22549. Doi: 10.1590/s2175-97902023e22549 (M23)
Bašić J, Milošević V, Đorđević B, Stefanović N, Cvetković M, Jevtović-Stoimenov T, Stojanović I. 2023. Association of the apolipoprotein E ε4 allele in a Serbian population with Alzheimer’s dementia. Archives of Biological Sciences 2023; 75 (3): 319-325. DOI: 10.2298/ABS230614026B IF:0.9 (M23)
Cvetkovic T, Saric S, Stefanovic N, Stojiljkovic V, Djordjevic B, Stojanovic D, Cvetkovic M, Deljanin Ilic M. Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure. J Int Med Res. 2022; 50(12) :3000605221139711. DOI: 10.1177/03000605221139711 (M23)
Catić-Đorđević A, Stefanović N, Pavlović I, Pavlović D, Živanović S, Kundalić A, Veličković Radovanović R, Mitić B. Utility of salivary mycophenolic acid concentration monitoring: Modeling and Monte Carlo validation approach. Pharmacol Res Perspect. 2022; 10: e01034. DOI:10.1002/prp2.103 (M23)
Veličković-Radovanović R, Stefanović N, Damnjanović I, Kocić B, Mladenović-Antić S, Dinić M, Petrović J, Mitić R, Catić-Đorđević A. Antibiotic utility and susceptibility changes of multidrug-resistant Escherichia coli and Klebsiella spp: 5-year experience in a tertiary healthcare centre. Eur J Hosp Pharm. 2021; 29 (2): 84-89. doi: 10.1136/ejhpharm-2021-002758. (ИФ2=2,537; ИФ5=2,094) M23
Stefanović N, Veličković-Radovanović R, Danković K, Pavlović I, Catić-Đorđević A, Bašić J, Despotović M, Jevtović-Stoimenov T, Mitić B, Cvetković T. Effect of the Interrelation between CYP3A5 Genotype, Concentration/Dose Ratio and Intrapatient Variability of Tacrolimus on Kidney Graft Function: Monte Carlo Simulation Approach. Pharmaceutics. 2021; 13(11):1970. doi: 10.3390/pharmaceutics13111970 (ИФ2=6,525; ИФ5=7,227) M21
Catić-Đorđević A, Pavlović I, Spasić A, Stefanović N, Pavlović D, Damnjanović I, Mitić B, Veličković-Radovanović R. Assessment of pharmacokinetic mycophenolic acid clearance models using Monte Carlo numerical analysis. Xenobiotica 2021; 51(4):387-393. doi: 10.1080/00498254.2020.1871532.. (ИФ2=1,997; ИФ5=1,785) M23
Stefanović NZ, Veličković-Radovanović RM, Danković KS, Mitić BP, Paunović GJ, Cvetković MB, Cvetković TP. Combined Effect of Inter- and Intrapatient Variability in Tacrolimus Exposure on Graft Impairment Within a 3-Year Period Following Kidney Transplantation: A Single-Center Experience. Eur J Drug Metab Pharmacokinet 2020; 45(6):749-760. doi: 10.1007/s13318-020-00644-2. (ИФ2=2,448; ИФ5=2,204) M23
Stefanović NZ, Veličković-Radovanović RM, Danković KS, Catić-Djordjević AK, Damnjanović ID, Mitić BP, Cvetković MB, Cvetković TP. Insight into the potential influence of inter- and intra-individual variability of tacrolimus exposure on graft function decline in three-year period following kidney transplantation. Farmacia 2020; 68 (6): 1036-1046. doi: 10.31925/farmacia.2020.6.10. (ИФ2=1,433; ИФ5=1,099) M23
Matejić JS, Stefanović N, Ivković M, Živanović N, Marin PD, Džamić AM. Traditional uses of autochthonous medicinal and ritual plants and other remedies for health in Eastern and South-Eastern Serbia. J Ethnopharmacol 2020; 261: 113186. doi: 10.1016/j.jep.2020.113186. (ИФ2=4,360; ИФ5=4,489) M21
Stojanovic D, Mitic V, Stojanovic M, Petrovic D, Ignjatovic A, Stefanovic N, Cvetkovic T, Kocic G, Bojanic V, Deljanin Ilic M. The partnership between renalase and ejection fraction as a risk factor for increased cardiac remodeling biomarkers in chronic heart failure patients. Curr Med Res Opin 2020; 36(6): 909-919. DOI: 10.1080/03007995.2020.1756233. (ИФ2=2,580; ИФ5=2,491) M22
Mitic VT, Stojanovic DR, Deljanin Ilic MZ, Stojanovic MM, Petrovic DB, Ignjatovic AM, Stefanovic NZ, Kocic GM, Bojanic VV. Cardiac Remodeling Biomarkers as Potential Circulating Markers of Left Ventricular Hypertrophy in Heart Failure with Preserved Ejection Fraction. Tohoku J Exp Med 2020; 250(4): 233-242. DOI: 10.1620/tjem.250.233. (ИФ2=1,848; ИФ5=2,058) M22
Stojanovic D, Mitic V, Petrovic D, Stojanovic M, Ignjatovic A, Stefanovic N, Cvetkovic T, Bojanic V, Kocic G, Ilic MD. Association of Plasma Renalase and Left Ventricle Mass Index in Heart Failure Patients Stratified to the Category of the Ejection Fraction: A Pilot Study. Dis Markers 2019; 2019:7265160. DOI: 10.1155/2019/7265160. (ИФ2=2,738; ИФ5=2,903) M22
Damnjanovic I, Stefanovic N, Zlatkovic-Guberinic S, Damnjanovic Z, Catic-Djordjevic A, Velickovic-Radovanovic R. Self-medication practices among the patients with chronic venous disease. Farmacia 2020; 68 (2): 225-231. doi: 10.31925/farmacia.2020.2.6. (ИФ2=1,433; ИФ5=1,099) M23
Spasić A, Catić-Đorđević A, Veličković-Radovanović R, Stefanović N, Džodić P, Cvetković T. Adverse effects of mycophenolic acid in renal transplant recipients: gender differences. Int J Clin Pharm 2019; 41(3):776-784. DOI: 10.1007/s11096-019-00837-z. (ИФ2=1,616; ИФ5=2,054) M23
Apostolović B, Cvetković T, Stefanović N, Apostolović S, Apostolović MA, Mitić B, Radovanović RV, Paunović K, Ignjatović A, Cvetković M, Stević N, Pavlović D. The predictive value of Klotho polymorphism, in addition to classical markers of CKD-MBD, for left ventricular hypertrophy in haemodialysis patients. Int Urol Nephrol 2019; 51(8):1425-1433. DOI: 10.1007/s11255-019-02193-3. (ИФ2=1,843; ИФ5=1,699) M23
Catić-Đorđević A, Pavlović I, Pavlović D, Stefanović N, Mikov M, Cvetković T, Veličković-Radovanović R. Evaluation of gender-based limited sampling methods for tacrolimus exposure after renal transplantation using the Monte Carlo simulation. Pharmazie 2018; 73: 482-485. DOI: 10.1691/ph.2018.8461 (ИФ2=0,820; ИФ5=1,004) M23
Stojanovic D, Cvetkovic T, Stojanovic M, Stefanovic N, Velickovic-Radovanovic R, Zivkovic N. Renalase Assessment With Regard to Kidney Function, Lipid Disturbances, and Endothelial Dysfunction Parameters in Stable Renal Transplant Recipients. Prog Transplant 2017; 27(2):125-130. doi: 10.1177/1526924817699956. (ИФ2=1,000; ИФ5=1,200) M23
Catić-Đorđević A, Cvetković T, Stefanović N, Veličković-Radovanović R. Current biochemical monitoring and risk management of immunosuppressive therapy after transplantation. J Med Biochem 2017; 36(1): 1-7. DOI: 10.1515/jomb-2016-0029 (ИФ2= 1,378; ИФ5= 0,704) M23
Damnjanovic I, Kitic D, Stefanovic N, Velickovic-Radovanovic R. Reply to Letter to the Editor: Herbal self-medication use in Type 2 diabetes mellitus. Turk J Med Sci 2016; 46 (4): 1275-1276. DOI:10.3906/sag-1507-97 (ИФ2=0,641; ИФ5=0,605) M26
Stefanović NZ, Cvetković TP, Jevtović-Stoimenov TM, Zvezdanović-Čelebić LV, Stojanović DR, Ignjatović AM, Živković ND, Veličković-Radovanović RM. Potential role of tacrolimus in erythrocytes'antioxidative capacity in long-term period after renal transplantation. Eur J Pharm Sci 2015; 70: 132-139. DOI: 10.1016/j.ejps.2015.01.013 (ИФ2=3,773; ИФ5=3,752) M21
Stefanović NZ, Cvetković TP, Veličković–Radovanović RM, Jevtović–Stoimenov TM, Vlahović PM, Stojanović IR, Pavlović DD. Pharmacogenetics may influence tacrolimus daily dose, but not urinary tubular damage markers in long-term period after renal transplantation. J Med Biochem 2015; 34(4): 422-430. DOI: 10.1515/jomb-2015-001 (ИФ2=1,045; ИФ5= 0,668) M23
Stefanović NZ, Cvetković TP, Jevtović-Stoimenov TM, Ignjatović AM, Paunović GJ, Veličković–Radovanović RM. Investigation of CYP 3A5 and ABCB1 gene polymorphisms in the long-term following renal transplantation: Effects on tacrolimus exposure and kidney function. Exp Ther Med 2015; 10: 1149-1156. DOI: 10.3892/etm.2015.2598 (ИФ2=1,280; ИФ5=1,326) M23
Veličković-Radovanović R, Stefanović N, Damnjanović I, Kocić B, Antić S, Dinić M, Petrović J, Mitić R, Catić-Djordjević A. Monitoring of antibiotic consumption and development of resistance by enterobacteria in a tertiary care hospital. J Clin Pharm Ther 2015; 40 (4): 426-430. DOI: 10.1111/jcpt.12283 (ИФ2=1,833; ИФ5=1,804) M23
Stojanovic D, Cvetkovic T, Stojanovic M, Bojanic V, Stefanovic N, Stojanovic I. The Assessment of Renalase: Searching for the Best Predictor of Early Renal Dysfunction by Multivariate Modeling in Stable Renal Transplant Recipients. Ann Transplant 2015; 20: 186-192. DOI: 10.12659/AOT.892632 (ИФ2=1,032; ИФ5=1,069) M23
Damnjanovic I, Kitic D, Stefanovic N, Zlatkovic - Guberinic S, Catic - Djordjevic A, Velickovic - Radovanovic R. Herbal self - medication use in patients with diabetes mellitus type 2. Turk J Med Sci 2015; 45 (4): 964-971. DOI: 10.3906/sag-1410-60 (ИФ2=0,841; ИФ5=0,633) M23
Veličković-Radovanović RM, Janković SM, Milovanović JR, Catić-Đorđević AK, Spasić AA, Stefanović NZ, Džodić PLj, Šmelcerović AA, Cvetković TP. Variability of mycophenolic acid elimination in the renal transplant recipients – population pharmacokinetic approach. Ren Fail 2015; 37(4): 652-658. DOI: 10.3109/0886022X.2015.1010442 (ИФ2=0,875; ИФ5=0,936) M23
Cvetković Т, Veličković-Radovanović R, Stojanović D, Stefanović N, Ignjatović A, Stojanović I, Sladojević N, Pavlović D. Oxidative and nitrosative stress in stable renal transplant recipients with respect to immunosuppression protocol- differences or similarities? J Med Biochem 2015; 34 (3): 295-303. DOI: 10.2478/jomb-2014-0047 (ИФ2=1,045; ИФ5= 0,668) M23
Velickovic-Radovanovic R, Mikov M, Catic-Djordjevic A, Stefanovic N, Mitic B, Paunovic G, Cvetkovic T. Gender-dependent predictable pharmacokinetic method for tacrolimus exposure monitoring in kidney transplant patients. Eur J Drug Metab Pharmacokinet 2015; 40(1): 95-102. DOI: 10.1007/s13318-014-0184-y (ИФ2=1,680; ИФ5=1,343) M23
Ljubisavljevic S, Stojanovic I, Cvetkovic T, Vojinovic S, Stojanov D, Stojanovic D, Stefanovic N, Pavlovic D. Erytrocytes’ antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation. J Neurol Sci 2014; 337: 8-13. DOI: 10.1016/j.jns.2013.11.006 (ИФ2=2,474; ИФ5=2,535)
Cvetkovic TP, Stefanovic NZ, Velickovic-Radovanovic RM, Paunovic GJ, Djordjevic VM, Stojanovic DR, Stojanovic IR, Pavlovic DD. Gender differences in oxidative and nitrosative stress parameters in kidney transplant patients on tacrolimus based immunosuppression. Int Urol Nephrol 2014; 46(6): 1217-1224. DOI: 10.1007/s11255-013-0577-x (ИФ2=1,519; ИФ5=1,388) M22
Nikolic VN, Jankovic SM, Velickovic-Radovanović R, Apostolović S, Stanojevic D, Zivanovic S, Stefanovic N, Pesic S, Jevtovic-Stoimenov T, Djuric J, Markovic V, Milovanovic JR. Population pharmacokinetics of carvedilol in patients with congestive heart failure. J Pharm Sci 2013; 102(8): 2851-2858. DOI: 10.1002/jps.23626 (ИФ2=3,007; ИФ5=3,419) M22
Nikolic VN, Jevtovic-Stoimenov T, Stokanovic D, Milovanovic M, Velickovic-Radovanovic R, Pesic S, Stoiljkovic M, Pesic G, Ilic S, Deljanin-Ilic M, Marinkovic D, Stefanovic N, Jankovic SM. An inverse correlation between TNF alpha serum levels and heart rate variability in patients with heart failure. J Cardiol 2013; 62(1): 37-43. DOI: 10.1016/j.jjcc.2013.02.013 (ИФ2=2,566; ИФ5=1,831) M23
Nikolic VN, Jevtovic-Stoimenov T, Velickovic-Radovanović R, Ilic S, Deljanin-Ilic M, Marinkovic D, Apostolović S, Stanojevic D, Zivanovic S, Stefanovic N, Pesic S, Ruzic Zecevic D, Milovanovic JR, Jankovic SM. Population pharmacokinetics of bisoprolol in patients with chronic heart failure. Eur J Clin Pharmacol 2013; 69(4): 859-865. DOI: 10.1007/s00228-012-1427-y (ИФ2=2,697, ИФ5=2,822) M23
Stojanovic D, Cvetkovic T, Stojanovic M, Bojanic V, Stefanovic N, Radenkovic S, Ljubisavljevic S, Pavlovic D. Crosstalk of inflammatory mediators and lipid parameters as early markers of renal dysfunction in stable renal transplant recipients with regard to immunosuppression. Ann Transplant 2013; 18: 414-423. DOI: 10.12659/AOT.889239 (ИФ2=1,430; ИФ5=1,260) M23
Velickovic-Radovanovic R, Mikov M, Catic-Djordjevic A, Stefanovic N, Stojanovic M, Jokanovic M, Cvetkovic T. Tacrolimus as a part of immunosuppressive treatment in kidney transplantation patients: sex differences. Gend Med 2012; 9(6): 471-480. DOI:10.1016/j.genm.2012.10.003 (ИФ2=1,690; ИФ5=2,481) M22
Dimitrijevic ZM, Cvetkovic TP, Djordjevic VM, Pavlovic DD, Stefanovic NZ, Stojanovic IR, Paunovic GJ, Velickovic-Radovanovic RM. How the duration period of erythropoietin treatment influences the oxidative status of hemodialysis patients. Int J Med Sci 2012; 9(9): 808-815. DOI: 10.7150/ijms.4910 (ИФ2=2,065) M21
Cvetković T, Pavlović R, Đorđević V, Stojanović I, Veličković-Radovanović R, Ignjatović A, Stefanović N, Živanović S, Đorđević V. Dimethylarginines – biomarkers in progression of kidney disease. J Med Biochem 2012; 31(4): 301-308. DOI: 10.2478/v10011-012-0029-7 (ИФ2=1,084) M23
Cvetković T, Veličković–Radovanović R, Djordjević V, Radenković S, Vlahović P, Stefanović N. Evidences for oxidative stress in essential hypertension. Cent Eur J Med 2012; 7(5): 610–616. DOI: 10.2478/s11536-012-0043-7 (ИФ2=0,262; ИФ5=0,265) M23
Catic–Djordjevic A, Velickovic–Radovanovic R, Stefanovic N, Cvetkovic T. Interactions between Tacrolimus and Metronidazole in a renal transplant patient. Cent Eur J Med 2012; 7(5): 587–590. DOI: 10.2478/s11536-012-0035-7 (ИФ2=0,262; ИФ5=0,265) M23
-
Radovi u ostalim časopisima:
Krstić N, Stefanović N, Gocić V, Ilić K, Damnjanović I. Influence of polypharmacy on the functional ability of patients with rheumatoid arthritis. Acta Medica Medianae 2022; 61(4): 24-30. (M52)
Veličković S, Vučić M, Stefanović N, Veličković F, Mauroudi E, Papadaki HA, Catić Djordjević A. Steps in diagnosis of chronic idiopathic neutropenia: is it the time for serbian patient registry? Acta Medica Medianae 2022; 61(1):85-90. DOI:10.5633/amm.2022.0112 (M52)
Catić Djordjević A, Stefanović N, Spasić A, Damnjanović I, Veličković Radovanović R, Djindjić B, Pavlović D. current overview of COVID-19 vaccination process in Serbia. Acta medica Medianae 2021; 60(3): 20-29. doi: 10.5633/amm.2021.0303 (M52)
Danković K, Stefanović N, Veličković-Radovanović R, Mitić B, Paunović G, Cvetković M, Cvetković T. Potential significance of bradykinin 2 receptor genotyping in kidney transplant recipients. Acta medica Medianae 2021; 60 (1): 19-27. doi: 10.5633/amm.2021.0103 (M52)
Koraćević M, Catić-Đorđević A, Stefanović N, Damnjanović I, Stošić I, Veličković-Radovanović R. The justification of clinical pharmacy skills and knowledge for modern community pharmacist. Acta medica Medianae 2020; 59(1): 14-22. doi:10.5633/amm.2020.0102 (M52)
Stefanović N, Veličković-Radovanović R, Catić-Đorđević A, Damnjanović I, Dinić K, Mitić B, Jevtović-Stoimenov T, Bašić J, Despotović M, Cvetković T. Interindividual and intraindividual pharmacokinetic variability of tacrolimus within the first year after renal transplantation: effect of CYP3A5 gene polymorphism. Acta medica Medianae 2019; 58(1):93-101. doi:10.5633/amm.2019.0113 (M51)
Stefanović NZ, Cvetković TP, Dinić KS, Mitić BP, Paunović GJ, Damnjanović ID, Catić-Đorđević AK, Veličković-Radovanović RM. Influence of Diff erent Formulations of Tacrolimus on Dosage Regimen and Drug Exposure Within the First Year After Kidney Transplantation. Hospital Pharmacology - International Multidisciplinary Journal 2019; 6(2):774-784. doi:10.5937/hpimj1902774S (M53)
Nikolić V, Janković SM, Stokanović D, Konstantinović SS, Zvezdanović JB, Stefanović N, Lilić J, Apostolović SR, Jevtović-Stoimenov T, Milovanović JR. Population pharmacokinetics of 2-oxo-clopidogrel in patients with acute coronary syndrome. FACTA UNIVERSITATIS. Series: Medicine and Biology 2019; 21(2): 58-63. https://doi.org/10.22190/FUMB181224015N (M53)
Stević N, Stefanović N, VeličkovićRadovanović R, Apostolović B, Paunović K, Cvetković M, Virijević D, Cvetković T. The influence of ace inhibitors treatment on anemia parameters in patients on maintenance hemodialysis. Acta Medica Medianae 2017; 56(3): 107-115. DOI: 10.5633/amm.2017.0317. (M51)
Stefanović N, Cvetković T, Jevtović-Stoimenov T, Veličković-Radovanović R, Zvezdanović-Čelebić L. Glutathione peroxidase Pro200Leu gene polymorphism as a potential predictor of renal function decline in renal transplant recipients. Acta Medica Medianae 2017; 56(1): 17-23. DOI: 10.5633/amm.2017.0103. (M51)
Damnjanović I, Kitić D, Stefanović N, Zlatković–Guberinić S, Catić–Đorđević A, Veličković–Radovanović R. The use of herbal dietary supplements in diabetic patients: role of healthcare professionals. Acta Medica Medianae 2017; 56(4): 25-30. DOI: 10.5633/amm.2017.0404. (M51)
Džodić P, Veličković-Radovanović R, Šmelcerović A, Catić-Đorđević A, Stefanović N, Spasić A, Ilić D, Živanović S, Ilijev I. Validation of hplc method for the determination of mycophenolic acidin human plasma obtained from renal transplant recipients. Acta Medica Medianae 2016; 55(4): 28-36. DOI:10.5633/amm.2016.0404 (M51)
Veličković-Radovanović R, Stefanović N, Damnjanović I, Petrović J, Mitić R, Kocić B, Antić S, Dinić M, Catić-Đorđević A. The Analysis of Antibiotic Consumption and Bacterial Resistance in Tertiary Healthcare Centre Niš. Hospital Pharmacology - International Multidisciplinary Journal 2016; 3(1):341-347. DOI:10.5937/HPIMJ1601341V (M53)
Veličković-Radovanović R, Stefanović N, Damnjanović I, Petrović J, Mitić R, Lilić R, Kocić B, Antić S, Dinić M, Catić-Đorđević A. Monitoring of the cephalosporins consumption in the tertiary care hospital. Acta Medica Medianae 2015; 54(2):31-36. DOI:10.5633/amm.2015.0205 (M51)
Spasić A, Veličković Radovanović R, Catić Đorđević A, Stefanović N, Cvetković T. Quality of Life in Type 2 Diabetic Patients. Acta Facultatis Medicae Naissensis 2014; 31 (3):193–200. DOI: 10.2478/afmnai-2014-0024 (M52)
Dimitrijević M, Catić-Đorđević A, Stefanović N, Pavlović D, Veličković-Radovanović R. Self-medication in primary healthcare in the territory ofthe city of niš. Acta Medica Medianae 2014; 53(3): 19-24. DOI:10.5633/amm.2014.0303 (M52)
Catić – Đorđević A, Nikolić V, Živanović S, Stefanović N, Veličković – Radovanović R. Carvedilol population pharmacokinetic analysis – applied validation procedure. Acta Medica Medianae 2013; 52(3): 18-24. DOI:10.5633/amm.2013.0303 (M52)
Stefanović N, Cvetković T, Veličković-Radovanović R, Jevtović-Stoimenov T, Stojanović D, Živković N. Significance of CYP3A5 gene polymorphism in Serbian renal transplant patients. Acta Medica Medianae 2013; 52(1): 33-38. DOI:10.5633/amm.2013.0105 (M52)
-
Radovi na naučnim skupovima međunarodnog značaja:
Cvetkovic T, Stevic N, Stefanovic N, Cosic V, Cvetkovic M, Stoiljkovic V, Dimitrijevic Y, Mitic B. Are soluble erythropoietin receptor, IL-6 and ACE potential predictors of hypo responsiveness to erythropoiesis stimulating agents (ESA) treatment in maintenance hemodialysis (HD) Patients? 24th International Congress of Clinical Chemistry and Laboratory Medicine and 16th Asia-Pacific Congress of Clinical Biochemistry, 26-30 June, 2022, Seoul, Korea (Abstract Book in Special Issue of Clinica Chimica Acta 2022; 530: S224-S224, W022) M34
Stojiljkovic V, Cvetkovic T, Cosic V, Stojiljkovic S, Zvezdanovic L, Cvetkovic M, Stefanovic N. The importance of cytokine concentration measurement in the assessment of allograft rejection in renal transplant patients. 24th International Congress of Clinical Chemistry and Laboratory Medicine and 16th Asia-Pacific Congress of Clinical Biochemistry, 26-30 June, 2022, Seoul, Korea (Abstract Book in Special Issue of Clinica Chimica Acta 2022; 530: S226-S227, W027) M34
Stefanovic N, Cvetkovic T, Velickovic-Radovanovic R, Mitic B, Damnjanovic I, Catic-Djordjevic A, Pavlovic D. The influence of tacrolimus intraindividual variability and CYP3A5 gene polymorphism on kidney function in late period after kidney transplantation. 5th ESPT Congress, 16-18 October, 2019, Seville, Spain (Abstract Book: /)
Damnjanovic I, Velickovic-Radovanovic R, Stefanovic N, Catic – Djordjevic A, Damnjanovic Z, Milic D. Self-medication frequency in the patient with chronic venous diseases. 10th Balkan Venous Forum, 1 & 2 November 2019, Thessaloniki, Greece.
Catić-Đorđević A, Spasić A, Stefanović N, Damnjanović I, Velicković-Radovanović R, Pavlović D. Self-medication in pregnant and breastfeeding women. 53. Days of preventive medicine, 24-27 September, 2019, Niš, Serbia (Abstract Book: 58) M34
Stefanović N, Cvetković T, Jevtović-Stoimenov T, Stojiljković V, Petković I, Veličković-Radovanović R. MNSOD Ala-9Val and GPX1 Pro200Leu gene polymorphisms as potential predictors of renal function decline in renal transplant recipients on tacrolimus-based immunosuppression. 4th ESPT Summer School, 24-27 September, 2018, Geneva, Switzerland (Abstract Book: ID 17250 PIN 028) M34
Catić-Dorđević A, Stefanović N, Damnjanović I, Bojanić N, Veličković-Radovanović R. Medication review as a tool to optimize prescribing in residential home center for elderly. 35th Balkan medical week, 25-27. Septembar, 2018, Athens, Greece (Abstract Book in Archieves of the Balkan Medical Union 2018; 53 (Suppl. 1): s155-s156) M34
Stefanovic N, Cvetkovic T, Paunovic G, Jevtovic-Stoimenov T, Catic-Djordjevic A, Velickovic-Radovanovic R. Relationship between gene variability of antioxidative enzymes and renal function decline in renal transplant recipients: two year post-transplant follow-up. 18th Congress of the European Society for Organ Transplantation, 24-27 September, 2017, Barcelona, Spain (Abstract Book in Transplant International 2017; 30 (Suppl. 2): 376) M34
Cvetkovic T, Stefanovic N, Paunovic G, Pavlovic D, Jevtovic-Stoimenov T, Velickovic-Radovanovic R. The significance of urinary markers in the evaluation of graft injury in renal transplant patients. 18th Congress of the European Society for Organ Transplantation, 24-27 September, 2017, Barcelona, Spain (Abstract Book in Transplant International 2017; 30 (Suppl. 2): 302) M34
Stefanović N, Cvetković T, Veličković-Radovanović R, Jevtović-Stoimenov T. Simultaneous implementation of pharmacogenetic testing, biochemical and therapeutic monitoring represents the backbone of personalized medicine. XX Congress of medical biochemistry and laboratory medicine with international participation, 25-27 May, 2016, Belgrade, Serbia (Abstract Book in Journal of Medical Biochemistry 2016; 35(2): 190-191) M32
Catić-Đorđević A, Cvetković T, Stefanović N, Veličković-Radovanović R. Monitoring of biochemical parameters in the assessment of immunosuppressive therapy safety. XX Congress of medical biochemistry and laboratory medicine with international participation, 25-27 May, 2016, Belgrade, Serbia (Abstract Book in Journal of Medical Biochemistry 2016; 35(2): 186-187). M32
Damnjanović I, Catić Đorđević A, Stefanović N, Zlatković Guberinić S, Milošević D, Veličković Radovanović R. Influence of health care professionals in preventing medication errors. 50. Days of preventive medicine, 27th-30th September, 2016, Niš, Serbia (Abstract Book: 234) M34
Stefanovic NZ, Cvetkovic TP, Jevtovic-Stoimenov TM, Catic-Djordjevic AK, Cvetkovic MB, Vujic SS, Velickovic-Radovanovic RM. Superoxide dismutase and glutathione peroxidase genotypes as potential predictors of renal function decline in renal transplant recipients. 53 rd ERA – EDTA Congress, 21-24 May, 2016, Vienna, Austria (Abstract Book in Nephrol Dial Transpl 2016; 31 (Suppl 1): 1575) M34
Apostolović B, Cvetković T, Anđelković-Apostolović M, Paunović K, Stefanović N, Stević N, Veličković-Radovanović R. Predictive risk factors for cardiovascular mortality in hemodialysis patients. 2th International Cardionephrology and Hypertension Congress. 7-9 May, 2015. Nis, Serbia (Abstract Book: 159-168 ) M33
Damnjanović I, Kitic D, Stefanovic N, Zlatkovic-Guberinić, Catic-Djordjevic A, Velicković-Radovanović R. Use of herbal dietary supplements in patients with diabetes mellitus type 2. 49. Days of preventive medicine, 22th-25th September, 2015, Niš, Serbia (Abstract Book: 54) M34
Velickovic–Radovanovic R, Paunovic G, Mitic B, Stefanovic N, Catic Đjordjevic A, Spasic A, Cvetkovic T. : Population pharmacokinetics of mycophenolic acid in renal transplant patients. 12th Congress BANTAO, 15-18 October, 2015, Croatia (Abstract Book: 65) M34
Stefanovic N, Velickovic–Radovanovic R, Jevtovic–Stoimenov T, Catic Đjordjevic A, Cvetkovic T. The Effect of CYP3A5 and ABCB1 gene polymorphisms on the tacrolimus exposure and renal function in long-term period after renal transplantation. 12th Congress BANTAO, 15-18 October, 2015, Croatia (Abstract Book: 59) M34
Cvetkovic T, Stefanovic N, Velickovic – Radovanovic R, Zvezdanovic-Celebic L, Paunovic G, Zivkovic N, Pavlovic D. Tacrolimus may act as an erythrocytes antioxidant in long – term period after renal transplantation. 52nd ERA – EDTA Congress, 28-31 May, 2015, London, United Kingdom (Abstract Book in Nephrol Dial Transpl 2015; 30 (Suppl 3): iii367) M34
Catić-Djordjević A, Stefanović N, Dimitrijevic M, Damnjanovic I, Nincic J, Veličković-Radovanović R. The role of clinical pharmacist in community pharmacy. VI Serbian congress of pharmacy with international participation, 15 – 10 October, 2014, Serbia (Abstract Book: 231) M34
Stefanovic N, Cvetkovic T, Velickovic–Radovanovic R, Jevtovic–Stoimenov T, Vlahovic P. Potential influence of tacrolimus dosage regimen as well as CYP 3A5 and ABCB1 polymorphism on the urinary nephrotoxicity markers in renaltransplant patients 51st ERA – EDTA Congress, 31 May – 03 June, 2014, Holand (Abstract Book in Nephrol Dial Transpl 2014; 29 (Suppl 3): iii316-iii317) M34
Cvetkovic T, Velickovic Radovanovic R, Djordjevic V, Stefanovic N, Paunovic G, Mitic B, Zivkovic N. Oxidative stress parameters in kidney transplant patients on tacrolimus based immunosupression in comparation of gender. 11th Congress BANTAO, 26-29 September, 2013, Romania (Abstract Book: 42) M34
Cvetković T, Stefanović N, Jevtović - Stoimenov T, Đorđević V, Zvezdanović - Čelebić L, Veličković - Radovanović R, Mitić B, Živković N, Pavlović D. Antioxidative enzymes and ala- 9 val polymorphism of mn-sod gene in renal transplant patients. 21st meeting of Balkan Clinical Laboratory Federation, 25-28 September, 2013, Montenegro (Abstract Book in Balkan Journal of Clinical Laboratory, 2013: 54) M34
Živković N, Stefanović N, Cvetković T, Veličković - Radovanović R, Đorđević B, Stefanović A. Plasma interleukin - 18, interleukin - 1β and TNF - α in kidney transplant patients on tacrolimus based immunosuppression. 21st meeting of Balkan Clinical Laboratory Federation, 25-28 September, 2013, Montenegro (Abstract Book in Balkan Journal of Clinical Laboratory, 2013: 130-131) M34
Veličkovic - Radovanovic R, Catic-Djordjevic A, Mitic. B, Stefanovic N, Cvetkovic T. Gender pharmacokinetics analysis of tacrolimus in kidney transplantation patients. 50th ERA – EDTA Congress, 18-21 May, 2013, Turkey (Abstract Book in Nephrol Dial Transpl 2013; 28 (Suppl 1): i276) M34
Cvetkovic T, Velickovic – Radovanovic R, Pavlovic R, Djordjevic V, Vlahovic P, Stefanovic N, Sladojevic N, Ignjatovic A. The level of arginine metabolic products in kidney transplant patients. 49th ERA – EDTA Congress, 24-27 May, 2012, France (Abstract Book in Nephrol Dial Transpl 2012; 27 (Suppl 2): ii523) M34
Vlahovic P, Cvetkovic T, Djordjevic V, Velickovic – Radovanovic R, Stefanovic N, Ignjatovic A, Sladojevic N. The effect of different calcineurin inhibitors on oxidative stress parameters in renal transplant recipients. 49th ERA – EDTA Congress, 24-27 May, 2012, France (Abstract Book in Nephrol Dial Transpl 2012; 27 (Suppl 2): ii525) M34
Stefanovic N, Cvetkovic T, Velickovic – Radovanovic R, Djordjevic V, Sladojevic N, Ignjatovic A, Zivanovic S, Pavlovic R. Determination of C-reactive protein, serum amyloid A and asymmetric dimethylarginine levels in patients on hemodialysis. 10th Congress BANTAO, 13-15 October, 2011, Greece (Abstract Book: 122) M34
Veličković –Radovanović R, Catić – Djordjević A, Mitić B, Cvetković T, Stefanović N. Rational immunosuppressive pharmacotherapy after kidney transplantation. 13th Serbian Congress of Pharmacologists and 3rd Serbian Congress of Clinical Pharmacology with international participation, 05-08 October, 2011, Serbia (Abstract Book: 157-158) M34
Nikolić V, Jevtović – Stoimenov T, Milovanović M, Pešić S, Stoiljković M, Marinković D, Stefanović N, Deljanin – Ilić M. Polymorphism of tumor necrosis factor-α in Serbian patients with heart failure.13th Serbian Congress of Pharmacologists and 3rd Serbian Congress of Clinical Pharmacology with international participation, 05-08 October, 2011, Serbia (Abstract Book: 106-107) M34
Stefanovic N, Velickovic – Radovanovic R, Catic – Djordjevic A, Cvetkovic T. Influence of immunosuppressive therapy on biochemical parameters in kidney transplant patients. 5th Congress of Pharmacy of Macedonia with international participation, 21-25 September, 2011, Macedonia (Abstract Book in Macedonian Pharmaceutical Bulletin 2011; 57 (Suppl): 329) M34
Cvetkovic T, Pavlovic R, Topalovic A, Pavlovic D, Djordjevic V, Velickovic–Radovanovic R, Djordjevic V, Stefanovic N. Dimethylarginines and classical inflammatory markers in hemodialysis patients. KARNEF 2011, 13-15 May, 2011, Niš, Serbia (Abstract book: 27-33) M33
Stefanovic N, Cvetkovic T, Velickovic – Radovanovic R, Radenkovic S, Stojanovic A, Kocic G. The role of oxidative stress in essential arterial hypertension (EAH) patients. 70th International Congress of FIP, 28 Avgust- 02 September, 2010, Portugal: LMCS – P – 016 M34
Cvetkovic T, Djordjevic V, Pavlovic R, Pavlovic D, Velickovic R, Sladojevic N, Stefanovic N. Dimethylarginines and inflammation markers in hemodialysis patients. XLVII ERA – EDTA Congress – II DGfN Congress, 25-28 June, 2010, Germany (Abstract Book in NDT Plus 2010; 3 (Suppl 3): iii73) M34
Cvetkovic T, Dimitrijevic Z, Aracki A, Stefanovic N, Sladojevic N, Topalovic A. The effect of erythropoietin to anemia parameters in hemodialysis patients. 17th Meeting of Balkan Clinical Laboratory Federation & 5th Macedonian Natioanal Congress of Medical Biochemists, 16-19 September, 2009, Macedonia (Abstract Book in Balkan Journal of Clinical Laboratory, Supplement 2009: 97) M34
-
Radovi na domaćim naučnim skupovima:
Stefanović N. Pharmacogenetics/pharmacogenomics in science and practice-the precision medicine era. Prvi Kongres Pharmanaissa, 23. i 24. septembar 2022, Niš, Srbija. (Sažetak štampan u Acta Medica Medianae 2022; 61 (3Suppl): 3-4.) (M64)
Katarina Danković, Nikola Stefanović, Stevan Vujić, Maša Jović, Radmila Veličković Radovanović. Potential influence of interleukin 6 gene polymorphism on graft function and tacrolimus dose-adjusted concentration in kidney transplant patients. Prvi Kongres Pharmanaissa, 23. i 24. septembar 2022, Niš, Srbija. (Sažetak štampan u Acta Medica Medianae 2022; 61 (3Suppl): 61-62.) (M64)
Ana Kundalić, Nikola Stefanović, Radmila Veličković-Radovanović, Aleksandra Catić-Đorđević. Adverse effects of immunosuppressive drugs in renal transplant recipients. Prvi Kongres Pharmanaissa, 23. i 24. septembar 2022, Niš, Srbija. (Sažetak štampan u Acta Medica Medianae 2022; 61 (3Suppl): 79-80.) (M64)
Stefanović N. Significance of determination of tacrolimus intraindividual variability and pharmacogenetic markers in kidney transplant recipients. VIII Kongres farmaceuta Srbije sa međunarodnim učešćem, 12-16. oktobar 2022, Beograd, Srbija (Sažetak štampan u Arhiv za farmaciju 2022; 72: S160–S161) (M62)
Ana Kundalić, Nikola Stefanović, Slavoljub Živanović, Radmila Veličković‐Radovanović, Aleksandra Catić‐Đorđević. Saliva as an alternative biological fluid for therapeutic drug monitoring of mycophenolic acid in renal transplant recipients. VIII Kongres farmaceuta Srbije sa međunarodnim učešćem, 12-16. oktobar 2022, Beograd, Srbija (Sažetak štampan u Arhiv za farmaciju 2022; 72: S436–S437) (M64)
Damnjanović I, Stefanović N, Damnjanović Z, Catić-Đorđević A, Veličković – Radovanović R. Pharmacotherapy and risk factors of intermittent claudication in patients with peripheral arterial disease. Drugi naučni simpozijum saveza farmaceutskih udruženja Srbije sa međunarodnim učešćem, 28. oktobar, 2021, Beograd, Srbija (Sažetak štampan u Arh. farm. 2021; 71: S108 – S109) (M64)
Danković K, Stefanović N, Damnjanović I, Catić-Đorđević A, Veličković-Radovanović R, Cvetković T. Potential significance of Bradykinin 2 receptor and/or angiotensin‐converting enzyme genotyping in kidney transplant recipients. Drugi naučni simpozijum saveza farmaceutskih udruženja Srbije sa međunarodnim učešćem, 28. oktobar, 2021, Beograd, Srbija (Sažetak štampan u Arh. farm 2021; 71: S110 – S113) (M64)
Stefanović N. Significance of pharmacogenetics in modern medicine and pharmacy. Drugi naučni simpozijum saveza farmaceutskih udruženja Srbije sa međunarodnim učešćem, 28. oktobar, 2021, Beograd, Srbija (Sažetak štampan u Arh. farm. 2021; 71: S16 – S17) (M62)
Stojiljkovic V, Cvetkovic T, Stefanovic N, Cvetkovic M, Cosic V. Effect of tacrolimus on glomerular filtration rate and lipid peroxidation in red blood cells in kidney transplant patients. Drugi naučni simpozijum saveza farmaceutskih udruženja Srbije sa međunarodnim učešćem, 28. oktobar, 2021, Beograd, Srbija (Sažetak štampan u Arh. farm. 2021; 71: S114 – S115) (M64)
Stefanović N, Danković K, Damnjanović I, Catić-Đorđević A, Cvetković T, Veličković-Radovanović R. Significance of simultaneous analysis of CYP3A5 genotype, concentration/dose ratio and intraindividual variability of tacrolimus in kidney transplant recipients. Drugi naučni simpozijum saveza farmaceutskih udruženja Srbije sa međunarodnim učešćem, 28. oktobar, 2021, Beograd, Srbija (Sažetak štampan u Arh. farm. 2021; 71: S116 – S117) (M64)
Stefanović N, Cvetković T, Mitić B, Paunović G, Veličković Radovanović R. Influence of intraindividual variability of tacrolimus exposure on long-term outcomes after kidney transplantation. 14. kongres farmakologa i 4. kongres kliničke farmakologije srbije sa međunarodnim učešćem, 18-21. septembar, 2019, Novi Sad, Srbija (Knjiga sažetaka: 103-104) M64
Veličković Radovanović R, Catić-Đorđević A, Stefanović N, Mitić B, Paunović G, Spasić A, Džodić P, Cvetković T. Pharmacokinetics of mycophenolic acid in patients with transplanted kidney. 14. kongres farmakologa i 4. kongres kliničke farmakologije srbije sa međunarodnim učešćem, 18-21. septembar, 2019, Novi Sad, Srbija (Knjiga sažetaka: 106-107) M64
Catić-Đorđević A, Stefanović N, Veličković-Radovanović R. STOPP/START criteria for optimization of pharmacotherapy in elderly. VII Kongres farmaceuta Srbije sa međunarodnim učešćem, 10-14. oktobar, 2018, Beograd, Srbija (Knjiga sažetaka u Arhiv za farmaciju 2018; 68(2): 218-219) M62
Stefanović N, Veličković-Radovanović R, Dinić K, Cvetković T. The role of pharmacogenetics in personalized therapy of renal transplant recipients on tacrolimus‐based immunosuppression. VII Kongres farmaceuta Srbije sa međunarodnim učešćem, 10-14. oktobar, 2018, Beograd, Srbija (Knjiga sažetaka u Arhiv za farmaciju 2018; 68(2): 292-293) M64
Spasić A, Catić-Đorđević A, Stefanović N, Veličković-Radovanović R. The influence of micophenolic acid formulation on the adverse effects in renal transplant recipients. VII Kongres farmaceuta Srbije sa međunarodnim učešćem, 10-14. oktobar, 2018, Beograd, Srbija (Knjiga sažetaka u Arhiv za farmaciju 2018; 68(3): 658-659) M64
Cvetković T, Apostolović B, Paunović K, Stefanović N, Anđelković-Apostolović M, Stević N, Veličković-Radovanović R. FGF-23, genski polimorfizam a-KLOTHO proteina i vitamin D u korelaciji sa markerima koštanog metabolizma kod pacijenata na dijalizi. 4. Kongres nefrologa Srbije, 3 – 6 novembar, 2016, Srbija (Knjiga sažetaka: 06) M64
Apostolović B, Cvetković T, Stefanović N, Anđelković-Apostolović M, Paunović K, Apostolović S, Veličković-Radovanović R, Stević N. Povezanost varijabilnosti na genu za KLOTHO protein i hipertrofije leve komore srca kod bolesnika na hemodijalizi. 4. Kongres nefrologa Srbije, 3 – 6 novembar, 2016, Srbija (Knjiga sažetaka: 19) M64
Catić-Djordjević A, Kocić D, Stefanović N, Veličković-Radovanović R. Adherence in patients with chronic kidney disease. VI week of the hospital clinical pharmacology, 28 - 29 November, 2014, Serbia (Abstract book: 20-21) M64
Veličković-Radovanović R, Cvetković T, Stefanović N. Značaj farmakogenetike kod bolesnika sa transplantiranim bubregom. 3. Kongres nefrologa Srbije, 23 – 26 oktobar, 2014, Srbija (Knjiga sažetaka: 8) M62
Stefanović N, Cvetković T, Veličković-Radovanović R, Jevtović-Stoimenov T, Živković N, Stojanović D. Potencijalni uticaj doznog režima takrolimusa na prametre oksidativnog i nitrozativnog stresa u plazmi u dugoročnom periodu nakon transplantacije bubrega. 3. Kongres nefrologa Srbije, 23 – 26 Oktobar, 2014, Srbija (Knjiga sažetaka: 69) M64
Cvetković T, Stefanović N, Veličković-Radovanović R, Jevtović-Stoimenov T, Zvezdanović-Čelebić L, Paunović G. Aktivnost antioksidativnih enzima i polimorfizma Ala-9Val za SOD i C599T za GPX kod pacijenata sa transplantiranim bubregom na terapiji takrolimusom: igrači u istom timu. 3. Kongres nefrologa Srbije, 23 – 26 Oktobar, 2014, Srbija (Knjiga sažetaka: 94) M64
Stefanovic N, Velickovic – Radovanovic R, Cvetkovic T, Jevtovic – Stoimenov T, Mitic B. The significance of CYP3A5 gene polymorphism in kidney transplantation. V week of the hospital clinical pharmacology, 29 November-01 December, 2013, Serbia (Аbstract book: 38-39) M64